Liquidia Corp Sustainability Reports
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products that address unmet patient needs, particularly for the treatment of rare cardiopulmonary diseases such as pulmonary arterial hypertension.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300O826O5VQJTG707
FIGI: BBG001V0GFD7
4 reports from 2020 to 2024
